CRIS Current Research Information System

CUCCHETTI, ALESSANDRO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 21.417
AS - Asia 18.437
EU - Europa 13.545
SA - Sud America 1.138
AF - Africa 1.125
OC - Oceania 27
Continente sconosciuto - Info sul continente non disponibili 7
Totale 55.696
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 21.184
VN - Vietnam 5.209
SG - Singapore 5.133
CN - Cina 3.925
GB - Regno Unito 3.130
IT - Italia 1.937
DE - Germania 1.924
HK - Hong Kong 1.600
NL - Olanda 1.392
SE - Svezia 1.336
IN - India 1.024
FR - Francia 855
BR - Brasile 814
RU - Federazione Russa 708
IE - Irlanda 527
UA - Ucraina 460
ZA - Sudafrica 315
JP - Giappone 303
CI - Costa d'Avorio 264
KR - Corea 261
FI - Finlandia 246
TG - Togo 243
CH - Svizzera 230
EE - Estonia 227
BG - Bulgaria 137
AR - Argentina 132
CA - Canada 120
PH - Filippine 115
JO - Giordania 109
SC - Seychelles 102
BD - Bangladesh 101
TH - Thailandia 95
AT - Austria 87
ID - Indonesia 84
IQ - Iraq 72
TR - Turchia 72
MX - Messico 69
NG - Nigeria 66
EC - Ecuador 61
BE - Belgio 59
PK - Pakistan 56
ES - Italia 51
PL - Polonia 50
SA - Arabia Saudita 44
TW - Taiwan 34
CL - Cile 31
UZ - Uzbekistan 31
HR - Croazia 28
CO - Colombia 27
IR - Iran 27
MA - Marocco 27
GR - Grecia 26
AU - Australia 25
MY - Malesia 24
EG - Egitto 22
PE - Perù 20
RO - Romania 19
VE - Venezuela 19
LT - Lituania 18
PY - Paraguay 18
ET - Etiopia 17
LB - Libano 17
CZ - Repubblica Ceca 15
DZ - Algeria 14
KE - Kenya 13
NP - Nepal 13
PT - Portogallo 11
TN - Tunisia 11
AZ - Azerbaigian 10
HU - Ungheria 10
JM - Giamaica 10
KZ - Kazakistan 10
MO - Macao, regione amministrativa speciale della Cina 10
UY - Uruguay 10
AE - Emirati Arabi Uniti 8
CR - Costa Rica 7
DK - Danimarca 7
DO - Repubblica Dominicana 7
NO - Norvegia 7
SK - Slovacchia (Repubblica Slovacca) 7
IL - Israele 6
OM - Oman 6
RS - Serbia 6
AL - Albania 5
KH - Cambogia 5
MK - Macedonia 5
PS - Palestinian Territory 5
BO - Bolivia 4
GH - Ghana 4
LU - Lussemburgo 4
MD - Moldavia 4
MM - Myanmar 4
SI - Slovenia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AF - Afghanistan, Repubblica islamica di 3
BH - Bahrain 3
BY - Bielorussia 3
BZ - Belize 3
CG - Congo 3
MN - Mongolia 3
Totale 55.622
Salva come PNG Salva come JPEG
Città #
Singapore 3.562
Fairfield 2.941
Southend 2.754
Ashburn 2.159
Hong Kong 1.497
Chandler 1.319
Woodbridge 1.208
Dong Ket 1.105
Ho Chi Minh City 1.087
Seattle 1.007
Wilmington 1.006
Houston 970
San Jose 919
Hanoi 832
Cambridge 821
Santa Clara 744
Princeton 683
Kerkrade 651
Ann Arbor 529
Dublin 525
Beijing 511
Bologna 484
Boardman 464
Frankfurt am Main 455
Hefei 418
Los Angeles 396
Lauterbourg 361
Eygelshoven 338
Westminster 276
Nanjing 267
Abidjan 264
Tokyo 255
Dallas 249
Lomé 243
Jacksonville 241
Padova 228
New York 218
Berlin 204
Seoul 193
Helsinki 184
Bern 174
Da Nang 170
Buffalo 163
Council Bluffs 146
San Diego 142
Jinan 138
Sofia 132
Haiphong 131
Shenyang 131
Milan 130
Saint Petersburg 130
Redondo Beach 128
Munich 121
Florence 119
Amman 105
Guangzhou 101
Delhi 92
São Paulo 92
Redmond 90
Shanghai 89
Changsha 86
Nanchang 85
Chicago 83
Dearborn 83
Turin 82
Hebei 71
The Dalles 71
Hải Dương 69
Des Moines 67
Hangzhou 60
Falls Church 58
London 58
Biên Hòa 57
Jiaxing 57
Tianjin 57
Zhengzhou 57
Abeokuta 55
Brussels 55
Johannesburg 54
Medford 52
Mülheim 52
Phoenix 52
Rome 51
Bengaluru 50
Norwalk 49
Amsterdam 48
Orem 45
Vienna 45
Falkenstein 44
Toronto 41
Olalla 40
Turku 40
Jakarta 39
Nuremberg 39
Wuhan 38
Can Tho 36
Ningbo 36
Paris 36
Yubileyny 36
Atlanta 34
Totale 37.260
Salva come PNG Salva come JPEG
Nome #
[Angiogenic factors and their relation to stage, lymph-node micrometastases and prognosis in patients operated on for gastric cancer] 1.629
Hepatobiliary Scintigraphy in the Preoperative Evaluation of Potential Living Liver Donors 497
A comprehensive analysis on expected years of life lost due to pancreatic cancer 309
Adding Liver Stiffness Measurement to the Routine Evaluation of Hepatocellular Carcinoma Resectability Can Optimize Clinical Outcome 301
Laser ablation is superior to TACE in large-sized hepatocellular carcinoma: A pilot case-control study 280
A new liver transplant priority for patients with hepatocellular carcinoma. 263
Alpha-fetoprotein has no prognostic role in small hepatocellular carcinoma identified during surveillance in compensated cirrhosis. 261
Accuracy of VirtualTouch Acoustic Radiation Force Impulse (ARFI) imaging for the diagnosis of cirrhosis during liver ultrasonography 261
Clinical Impact and Safety of Anticoagulants for Portal Vein Thrombosis in Cirrhosis 257
Burnout and psychological distress between surgical and non-surgical residents 254
Comprehensive surgical intestinal rescue and transplantation program in adult patients: Bologna experience. 246
ANGPT2 and NOS3 polymorphisms and clinical outcome in advanced hepatocellular carcinoma patients receiving sorafenib 241
A meta-analysis of single HCV-untreated arm of studies evaluating outcomes after curative treatments of HCV-related hepatocellular carcinoma 240
Radiomics of cholangiocarcinoma on pretreatment CT can identify patients who would best respond to radioembolisation 239
The Effect of a Liver Transplant Program on the Outcomes of Resectable Hepatocellular Carcinoma: A Nationwide Multicenter Analysis 235
Yttrium-90 radioembolization for unresectable/recurrent intrahepatic cholangiocarcinoma: a survival, efficacy and safety study 234
Pattern of macrovascular invasion in hepatocellular carcinoma 233
Recalibrating survival prediction among patients receiving trans‐arterial chemoembolization for hepatocellular carcinoma 233
Membrane localization of human equilibrative nucleoside transporter 1 in tumor cells may predict response to adjuvant gemcitabine in resected cholangiocarcinoma patients 225
Analysis of risk factors for tumor recurrence after liver transplantation for hepatocellular carcinoma: key role of immunosuppression. 221
Bacterial translocation in adult small bowel transplantation 219
Abdominal wall transplantation with microsurgical technique 219
Combined kidney-liver, heart-liver, and kidney-pancreas transplantations from a single deceased donor. 218
Yttrium-90 microsphere radioembolization in unresectable intrahepatic cholangiocarcinoma 218
Average treatment effect of hepatic resection versus locoregional therapies for hepatocellular carcinoma 217
BCLC stage B hepatocellular carcinoma and transcatheter arterial chemoembolization: a 20-year survey by the Italian Liver Cancer group. 216
Curative therapies are superior to standard of care (transarterial chemoembolization) for intermediate stage hepatocellular carcinoma. 216
Combined liver–dual kidney transplant: Role in expanded donors 215
Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon 215
Relationship between indocyanine green retention test, decompensation and survival in patients with Child-Pugh A cirrhosis and portal hypertension 214
An explorative data-analysis to support the choice between hepatic resection and radiofrequency ablation in the treatment of hepatocellular carcinoma. 213
Criteria for diagnosing benign portal vein thrombosis in the assessment of patients with cirrhosis and hepatocellular carcinoma for liver transplantation. 213
A Novel Nomogram to Predict the Prognosis of Patients Undergoing Liver Resection for Neuroendocrine Liver Metastasis: an Analysis of the Italian Neuroendocrine Liver Metastasis Database 212
Can antiplatelet prophylaxis reduce the incidence of hepatic artery thrombosis after liver transplantation? 211
Role of SIRT-3, p-mTOR and HIF-1α in Hepatocellular Carcinoma Patients Affected by Metabolic Dysfunctions and in Chronic Treatment with Metformin 211
Impact of model for end-stage liver disease (MELD) score on prognosis after hepatectomy for hepatocellular carcinoma on cirrhosis. 210
Comparison between alcohol- and hepatitis C virus-related hepatocellular carcinoma: clinical presentation, treatments and outcome. 210
Assessment of Radiofrequency Ablation Efficacy for Hepatocellular Carcinoma by Histology and Pre-transplant Radiology 209
Prognostic factors for tumor recurrence after a 12-year, single-center experience of liver transplantations in patients with hepatocellular carcinoma. 208
Application of the Intermediate-Stage Subclassification to Patients with Untreated Hepatocellular Carcinoma 208
Coping strategies in intestinal transplantation 208
Regret affects the choice between neoadjuvant therapy and upfront surgery for potentially resectable pancreatic cancer 207
Changes in the surgical approach to hilar cholangiocarcinoma during an 18-year period in a Western single center 207
Correlation between LDH levels and response to sorafenib in HCC patients: an analysis of the ITA.LI.CA. database 205
Analysis of risk factors for early hepatic artery thrombosis after liver transplantation. Possible contribution of reperfusion in the early morning. 204
Validation of noninvasive methods for the assessment of liver fibrosis in patients with recurrent hepatitis C after transplantation. 204
Anatomic variations of intrahepatic bile ducts in a European series and meta-analysis of the literature. 203
Pre-transplant psoas muscle density as a ready-to-use and low-cost predictor of patient survival after liver transplant 202
Development and Validation of a New Prognostic System for Patients with Hepatocellular Carcinoma 202
Italian experience in adult clinical intestinal and multivisceral transplantation: 6 years later. 202
Effect of different immunosuppressive schedules on recurrence-free survival after liver transplantation for hepatocellular carcinoma. 201
The changing scenario of hepatocellular carcinoma in Italy: an update 200
Artificial neural network is superior to MELD in predicting mortality of patients with end-stage liver disease. 199
External Validation of Surrogate Indices of Fatty Liver in the General Population: the Bagnacavallo Study 199
Conventional split liver transplantation for two adult recipients: a recent experience in a single European center 198
Influence of clinically significant portal hypertension on survival after hepatic resection for hepatocellular carcinoma in cirrhotic patients 198
Competing risk analysis on outcome after hepatic resection of hepatocellular carcinoma in cirrhotic patients. 198
Years of Life Lost for Older Patients After Colorectal Cancer Diagnosis 195
Implementation of a patient blood management in an Italian City Hospital: is it effective in reducing the use of red blood cells? 194
Conditional survival after hepatic resection for hepatocellular carcinoma in cirrhotic patients. 194
Metabolic disorders across hepatocellular carcinoma in Italy 194
Assessment of donor steatosis in liver transplantation: is it possible without liver biopsy? 193
Contrast-enhanced ultrasonography to diagnose complicated acute cholecystitis 190
Material deprivation affects the management and clinical outcome of hepatocellular carcinoma in a high-resource environment 190
In Reply 189
Daclizumab and alemtuzumab as induction agents in adult intestinal and multivisceral transplantation: rejection and infection rates in 40 recipients during the early postoperative period. 189
Assessment of perioperative transfusion requirement for cirrhotic patients undergoing elective hepatectomy 188
Impact of preoperative infection on outcome after liver transplantation 188
Comparison of recurrence of hepatocellular carcinoma after resection in patients with cirrhosis to its occurrence in a surveilled cirrhotic population. 186
Analysis of cardiovascular, acid-base status, electrolyte and coagulation changes during small bowel transplantation 185
Can the dropout risk of candidates with hepatocellular carcinoma predict survival after liver transplantation? 185
The role of metronomic capecitabine for treatment of recurrent hepatocellular carcinoma after liver transplantation 184
A new approach to the use of α-fetoprotein as surveillance test for hepatocellular carcinoma in patients with cirrhosis. 183
Cost-effectiveness of doxorubicin-eluting beads versus conventional trans-arterial chemo-embolization for hepatocellular carcinoma 182
Critical systematic review on hepatic resection and transarterial chemoembolization for hepatocellular carcinoma 181
Age and equity in liver transplantation: An organ allocation model. 179
Post-reperfusion syndrome during isolated intestinal transplantation: outcome and predictors 178
Assessment of long-term prognosis at detection of early hepatocellular carcinoma remains unsolved 178
Incidence, clinical significance, and outcome of vascular alterations in intestinal biopsies after isolated small bowel transplantation: a single-center experience. 178
Effectiveness and cost-effectiveness of peri-operative versus post-operative chemotherapy for resectable colorectal liver metastases. 178
Ablation and resection for hepatocellular carcinoma within Milan criteria and high alpha-foetoprotein levels 178
Survival and Tolerability of Transarterial Chemoembolization in Greater Versus less than 70 Years of Age Patients with Unresectable Hepatocellular Carcinoma: A Propensity Score Analysis 178
Incidence and management of abdominal closure-related complications in adult intestinal transplantation. 177
Clinical and molecular determinants of extrahepatic disease progression in patients with metastatic colorectal cancer with liver-limited metastases deemed initially unresectable 177
Analysis of factors affecting recurrence of hepatocellular carcinoma after liver transplantation with a special focus on inflammation markers. 176
Validation of response to yttrium-90 radioembolization for hepatocellular carcinoma with portal vein invasion 176
Pancreas: Comic Biography of an Organ 175
Preliminary results of a "prope" tolerogenic regimen with thymoglobulin pretreatment and hepatitis C virus recurrence in liver transplantation 174
Clinical outcomes after endoscopic submucosal dissection for colorectal neoplasia: A systematic review and meta-analysis 174
Liver transplantation for recurrent hepatocellular carcinoma on cirrhosis after liver resection: University of Bologna experience. 172
Survival After Transarterial Radioembolization in Patients with Unresectable Intrahepatic Cholangiocarcinoma: An Updated Meta-analysis and Meta-regression 171
Outcome of hepatocellular carcinoma in human immunodeficiency virus-infected patients. 170
Psychological Adaptation and Quality of Life of Adult Intestinal Transplant Recipients: University of Bologna Experience 170
Immunosuppression Modifications Based on an Immune Response Assay: Results of a Randomized, Controlled Trial. 169
Rejection episodes and 3-year graft survival under sirolimus and tacrolimus treatment after adult intestinal transplantation. 169
Machine Learning Predictive Model to Guide Treatment Allocation for Recurrent Hepatocellular Carcinoma After Surgery 168
Preoperative prediction of hepatocellular carcinoma tumour grade and micro-vascular invasion by means of artificial neural network: a pilot study. 168
Liver transplantations with donors aged 60 years and above: the low liver damage strategy 168
Actual Risk of Using Very Aged Donors for Unselected Liver Transplant Candidates: A European Single-center Experience in the MELD Era 168
Liver transplantation from hepatitis B surface antigen positive donors: a safe way to expand the donor pool. 168
Totale 22.095
Salva come PNG Salva come JPEG
Categoria #
all - tutte 152.619
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 152.619
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.192 0 0 0 0 0 0 0 0 0 218 196 1.778
2021/20226.222 472 228 353 386 575 297 149 441 259 295 1.855 912
2022/20236.206 633 959 330 736 395 483 212 349 1.106 160 493 350
2023/20241.784 132 303 137 165 154 361 76 108 100 124 63 61
2024/20257.588 351 1.170 671 604 1.151 408 463 208 127 535 333 1.567
2025/202618.968 1.536 1.352 1.639 1.282 1.952 2.244 3.155 612 3.727 1.469 0 0
Totale 56.757